Retinoic acid abolishes the calcitonin gene-related peptide autocrine system in F9 teratocarcinoma cells.
Calcitonin gene-related peptide (CGRP), expressed predominantly in F9 embryonal carcinoma cells, is both a potent chemotactic agent and an autocrine growth factor for these cells. We analyzed the effect of retinoic acid (RA)-induced differentiation of F9 cells into primitive parietal endoderm-like cells, on CGRP production and the CGRP responsiveness of these cells. Poly(A) RNA extracted from F9 cells and analysed by Northern blotting and hybridization with a CGRP probe showed a specific band of about 1200 bases corresponding to mature CGRP mRNA. This band was not detected in F9 cells treated for 6 days with RA (differentiated primitive parietal endoderm-like cells) or in PYS cells (established parietal endoderm-like cell line). During RA-induced differentiation of F9 cells, CGRP mRNA levels fell within 24 h after treatment and were almost undetectable after 2 days. RA treatment also reduced CGRP secretion by F9 cells; the effect was maximal at 3 days and remained stable thereafter. Similarly, RA rapidly reduced adenylate cyclase responsiveness to chicken CGRP (cCGRP) and human CGRP (hCGRP). An 80% fall in cAMP release into the culture medium in the presence of CGRP was observed after 24 h of RA treatment. These results demonstrate that RA rapidly abolishes the CGRP autocrine system involved in the proliferation of F9 cells, at the same time inducing their differentiation into primitive parietal endoderm. They point to the interaction between retinoic acid and growth factors in the regulation of cell proliferation and differentiation.
Segond
N
N
INSERM U 349, Paris, France.
Gerbaud
P
P
Taboulet
J
J
Jullienne
A
A
Moukhtar
M S
MS
Evain-Brion
D
D
D000262:Adenylyl Cyclases / Q000235:genetics*; D015152:Blotting, Northern; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis* / Q000502:physiology; D000242:Cyclic AMP / Q000032:analysis*; D017931:DNA Primers; D005163:Factor Analysis, Statistical; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger; D011863:Radioimmunoassay; D018243:Teratocarcinoma / Q000503:physiopathology*; D013736:Testicular Neoplasms / Q000503:physiopathology*; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D017931:DNA Primers; D012333:RNA, Messenger; D014212:Tretinoin; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D015740:Calcitonin Gene-Related Peptide